BASKING RIDGE, N.J., Aug. 29, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC, a company driven to create novel therapeutics to treat and prevent metastasis of cancers, today announced that Jonathan Chernoff, MD, PhD, Director of Fox Chase Cancer Center and world-renowned expert in translational research, precision medicine, signaling reprograming, and targeted therapies, has joined MetasTx scientific advisory board.